NewsBenzingaJazz Pharmaceuticals T3 BPA ajusté de (3,88 $) inférieur à l’estimation de (3,86 $), ventes de 1,243 Md$ supérieures à l’estimation de 1,208 Md$ Jazz Pharmaceuticals T3 BPA ajusté de (3,88 $) inférieur à l’estimation de (3,86 $), ventes de 1,243 Md$ supérieures à l’estimation de 1,208 Md$ Benzinga 2026.11.02 21:08 (GMT+0) Open on Benzinga Other news Billionaires Walk Away From Alphabet in Q3 - Hedge Funds Google ‘How to Sell’ and Hit Enter $100 Invested In Visa 15 Years Ago Would Be Worth This Much Today Western Digital Gains, Seagate Flat As Nvidia’s Raised Outlook Lifts AI Storage Hopes Home Depot Posts Strongest Comps In 4 Years, Analysts Revise Price Targets TJ Maxx Parent Bets on Accelerating Sales This Holiday Season Why Is Coinbase Stock Falling on Wednesday?